header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-28452
Fish name: zf169Tg
Genotype: zf169Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by zf169Tg
Human Disease Conditions Citations
acute myeloid leukemia standard conditions Liu et al., 2017
myelodysplastic syndrome standard conditions Liu et al., 2017
leukemia standard conditions Liu et al., 2017
acute lymphocytic leukemia standard conditions Liu et al., 2017
GENE EXPRESSION
Gene expression in zf169Tg
RNA expression
Expressed Gene Structure Conditions Figures
cebpa standard conditions Fig. 4 with image from Yuan et al., 2015
cpsf1 standard conditions Fig. 4 from Bolli et al., 2011
igiv1s1 standard conditions Fig. 4 from Liu et al., 2017
irf4a standard conditions Fig. 1 with image from Wang et al., 2015
itga2b standard conditions Fig. 5 with imageFig. 7 with image from Bertrand et al., 2008
lyz standard conditions Fig. 2 from Liu et al., 2017
mir34b standard conditions Fig. 1 with image from Wang et al., 2013
mir142a standard conditions Fig. 1 from Lu et al., 2013
myb standard conditions Fig. 1Fig. 6 from Liu et al., 2017
chemical treatment by environment: alvocidib Fig. 6 from Liu et al., 2017
ncam1a standard conditions Fig. S2 with image from Bertrand et al., 2008
ptprc standard conditions Fig. 5 with imageFig. 7 with imageFig. S2 with image from Bertrand et al., 2008
rfx2 standard conditions Fig. 1 with image from Wang et al., 2013
runx1 standard conditions Fig. 7 with image from Bertrand et al., 2008
trac standard conditions Fig. 4 from Liu et al., 2017
PHENOTYPE
Phenotype in zf169Tg
Phenotype Conditions Figures
blood lymphocyte increased amount, abnormal standard conditions Fig. 4 from Liu et al., 2017
blood lymphoid progenitor cell increased amount, abnormal standard conditions Fig. 4 from Liu et al., 2017
blood myeloblast increased amount, abnormal standard conditions Fig. 4 from Liu et al., 2017
blood island granulocyte increased amount, abnormal standard conditions Fig. 2 from Liu et al., 2017
granulocyte amount, ameliorated chemical treatment by environment: alvocidib Fig. 6 from Liu et al., 2017
granulocyte amount, ameliorated chemical treatment by environment: cytarabine Fig. 6 from Liu et al., 2017
granulocyte increased amount, abnormal standard conditions Fig. 2Fig. 6 from Liu et al., 2017
granulocyte increased amount, abnormal chemical treatment by environment: quizartinib Fig. 6 from Liu et al., 2017
granulocyte lyz expression increased distribution, abnormal standard conditions Fig. 2 from Liu et al., 2017
head kidney myb expression amount, ameliorated chemical treatment by injection: alvocidib Fig. 6 from Liu et al., 2017
head kidney myb expression increased amount, abnormal control Fig. 6 from Liu et al., 2017
head kidney erythroid lineage cell decreased amount, abnormal standard conditions Fig. 3 from Liu et al., 2017
head kidney lymphocyte amount, ameliorated chemical treatment by injection: alvocidib Fig. 6 from Liu et al., 2017
head kidney lymphocyte decreased amount, abnormal standard conditions Fig. 3Fig. 6 from Liu et al., 2017
head kidney lymphocyte increased amount, abnormal standard conditions Fig. 4 from Liu et al., 2017
head kidney myeloblast increased amount, abnormal standard conditions Fig. 4 from Liu et al., 2017
head kidney myeloid leukocyte amount, ameliorated chemical treatment by injection: alvocidib Fig. 6 from Liu et al., 2017
head kidney myeloid leukocyte increased amount, abnormal standard conditions Fig. 3Fig. 6 from Liu et al., 2017
head kidney neutrophil increased amount, abnormal standard conditions Fig. 4 from Liu et al., 2017
hematopoietic stem cell myb expression increased amount, abnormal standard conditions Fig. 1 from Liu et al., 2017
intermediate cell mass of mesoderm myb expression increased amount, abnormal standard conditions Fig. 1 from Liu et al., 2017
kidney myb expression increased amount, abnormal standard conditions Fig. 1 from Liu et al., 2017
kidney increased size, abnormal standard conditions Fig. 3 from Liu et al., 2017
kidney increased weight, abnormal standard conditions Fig. 3 from Liu et al., 2017
kidney granulocyte increased amount, abnormal standard conditions Fig. 2 from Liu et al., 2017
liver increased weight, abnormal standard conditions Fig. 3 from Liu et al., 2017
liver granulocyte increased amount, abnormal standard conditions Fig. 3 from Liu et al., 2017
myeloid cell cell population proliferation increased occurrence, abnormal standard conditions Fig. 3 from Liu et al., 2017
skeletal muscle myeloid cell increased amount, abnormal standard conditions Fig. 4 from Liu et al., 2017
ventral wall of dorsal aorta myb expression increased amount, abnormal standard conditions Fig. 1 from Liu et al., 2017
whole organism myb expression amount, ameliorated chemical treatment by environment: alvocidib Fig. 6 from Liu et al., 2017
whole organism igiv1s1 expression increased amount, abnormal standard conditions Fig. 4 from Liu et al., 2017
whole organism myb expression increased amount, abnormal control Fig. 6 from Liu et al., 2017
whole organism myb expression increased amount, abnormal chemical treatment by environment: quizartinib Fig. 6 from Liu et al., 2017
whole organism trac expression increased amount, abnormal standard conditions Fig. 4 from Liu et al., 2017

CITATIONS  (41)